Literature DB >> 2039320

Reducing postischemic paraplegia using conjugated superoxide dismutase.

J M Agee1, T Flanagan, L H Blackbourne, I L Kron, C G Tribble.   

Abstract

Paraplegia after thoracic aortic aneurysm repair has an incidence of 2.2% to 24%. Oxygen-derived free radicals after reperfusion of an ischemic spinal cord may be partly responsible for neuronal destruction. We studied the effects of polyethylene glycol-conjugated superoxide dismutase (PEG-SOD), a free radical scavenger, as a way of increasing spinal cord tolerance to ischemia. Thirty rabbits underwent 40 minutes of aortic occlusion (a known model of paraplegia). Ten of these animals received 25,000 U/kg of PEG-SOD 24 hours before aortic occlusion and two additional doses of 10,000 U/kg, one before and one subsequent to spinal ischemia. Ten animals received superoxide dismutase in the same dosages as those receiving PEG-SOD. Ten control animals received placebo. All animals were studied for 96 hours, at which time a final neurological examination was performed and the results were recorded. Of the 10 animals treated with PEG-SOD, 2 were completely paralyzed whereas 8 had less (7) or no (1) neurological impairment. Eight of the 10 control animals and 9 of the 10 animals receiving superoxide dismutase were completely paralyzed. None of the control animals or animals receiving superoxide dismutase had a normal neurological examination (p less than or equal to 0.05). Treatment with PEG-SOD before and during occlusion increased the rabbit spinal cord tolerance to a 40-minute ischemic insult. Scavenging free radicals may lessen experimental spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039320     DOI: 10.1016/0003-4975(91)91004-f

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1.

Authors:  Gu Gong; Li-bang Yuan; Ling Hu; Wei Wu; Liang Yin; Jing-li Hou; Ying-hai Liu; Le-shun Zhou
Journal:  Acta Pharmacol Sin       Date:  2011-12-12       Impact factor: 6.150

2.  Regional lidocaine infusion reduces postischemic spinal cord injury in rabbits.

Authors:  A Z Apaydin; S Büket
Journal:  Tex Heart Inst J       Date:  2001

Review 3.  Fighting spinal cord complication during surgery for thoracoabdominal aortic disease.

Authors:  Yutaka Okita
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-02-10

4.  Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system.

Authors:  Kallol Dutta; Debapriya Ghosh; Anirban Basu
Journal:  J Neuroimmune Pharmacol       Date:  2009-05-12       Impact factor: 4.147

5.  Hydroxysafflor Yellow A protects spinal cords from ischemia/reperfusion injury in rabbits.

Authors:  Le-qun Shan; Sai Ma; Xiu-chun Qiu; Yong Zhou; Yong Zhang; Lian-he Zheng; Peng-cheng Ren; Yu-cai Wang; Qing-yu Fan; Bao-an Ma
Journal:  BMC Neurosci       Date:  2010-08-13       Impact factor: 3.288

6.  Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following spinal cord ischemia in rabbits.

Authors:  Li-Hong Fan; Kun-Zheng Wang; Bin Cheng; Chun-Sheng Wang; Xiao-Qian Dang
Journal:  BMC Neurosci       Date:  2006-06-14       Impact factor: 3.288

7.  Tetramethylpyrazine attenuates spinal cord ischemic injury due to aortic cross-clamping in rabbits.

Authors:  Shaoyang Chen; Lize Xiong; Qiang Wang; Hanfei Sang; Zhenhua Zhu; Hailong Dong; Zhihong Lu
Journal:  BMC Neurol       Date:  2002-04-17       Impact factor: 2.474

Review 8.  Cerebrospinal fluid drainage for thoracic and thoracoabdominal aortic aneurysm surgery.

Authors:  Shaukat Nawaz Khan; Gerard Stansby
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

9.  Comparative effects of methylprednisolone and tetracosactide (ACTH1-24) on ischemia/reperfusion injury of the rabbit spinal cord.

Authors:  Hayri Kertmen; Erhan Celikoglu; Ozden Caglar Ozturk; Bora Gürer; Huseyin Bozkurt; Mehmet Ali Kanat; Ata Turker Arikok; Berrin Imge Erguder; Mustafa Fevzi Sargon; Zeki Sekerci
Journal:  Arch Med Sci       Date:  2017-01-31       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.